Skip to content
10-K

Annual Report

LIFECORE BIOMEDICAL, INC. LFCR

0001005286-25-000108

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 31, 2025 37.41M sh
Shares Diluted FY 2025 · May 25, 2025 34.82M sh
Shares Diluted restated FY 2025 · May 26, 2024 36.66M sh
Capex FY 2025 · May 25, 2025 $13.42M
Capex FY 2025 · May 26, 2024 $18.4M
Operating Cash Flow FY 2025 · May 25, 2025 −$206K
Operating Cash Flow restated FY 2025 · May 26, 2024 $257K
Short Term Debt FY 2025 · May 25, 2025 $3.44M
Short Term Debt restated FY 2025 · May 26, 2024 $943K
Cash And Equivalents FY 2025 · May 25, 2025 $8.27M
Cash And Equivalents FY 2025 · May 26, 2024 $8.46M
Stockholders Equity FY 2025 · May 25, 2025 $1.34M
Stockholders Equity FY 2025 · May 26, 2024 $11.32M
Stockholders Equity FY 2025 · May 28, 2023 −$4.23M
Current Liabilities FY 2025 · May 25, 2025 $30.18M
Current Liabilities FY 2025 · May 26, 2024 $38.87M
Total Liabilities FY 2025 · May 25, 2025 $191.91M
Total Liabilities FY 2025 · May 26, 2024 $200.06M
Current Assets FY 2025 · May 25, 2025 $85.68M
Current Assets FY 2025 · May 26, 2024 $81.03M
Total Assets FY 2025 · May 25, 2025 $239.34M
Total Assets FY 2025 · May 26, 2024 $253.96M
Eps Diluted FY 2025 · May 25, 2025 −$1.27
Eps Diluted restated FY 2025 · May 26, 2024 $0.33
Eps Basic FY 2025 · May 25, 2025 −$1.27
Eps Basic restated FY 2025 · May 26, 2024 $0.39
Sga Expense FY 2025 · May 25, 2025 $44.05M
Sga Expense FY 2025 · May 26, 2024 $40.46M
Rd Expense FY 2025 · May 25, 2025 $8.26M
Rd Expense FY 2025 · May 26, 2024 $8.58M
Net Income FY 2025 · May 25, 2025 −$38.72M
Net Income FY 2025 · May 26, 2024 $12.01M
Operating Income FY 2025 · May 25, 2025 −$17.25M
Operating Income FY 2025 · May 26, 2024 −$8.84M
Gross Profit FY 2025 · May 25, 2025 $40.3M
Gross Profit FY 2025 · May 26, 2024 $41.85M